Pfizer and BioNTech report positive data in trial of omicron-targeting bivalent booster in individuals aged 18 and older
Pfizer Inc. PFE, +0.26% and German partner BioNTech SE BNTX, +5.53% said Thursday early data…
Read MorePfizer Inc. PFE, +0.26% and German partner BioNTech SE BNTX, +5.53% said Thursday early data…
Read MoreUmbrella insurance is a hard sell for most people. Why? Because the concept of a…
Read MoreShukla Paksha and Krishna Paksha are based on cycles of the moon. The fifteen day…
Read More